Jaguar Health, Inc. (JAGX)
Data as of , from SEC Form 4 filings.
See up to 3 months of JAGX. The 7-day demo opens the 1M and 3M ranges and puts JAGX on your watchlist.
Start 7-day demoLatest JAGX insider trades
About Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. files with the SEC under CIK 0001585608 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector. A registration statement was filed on 16 July 2026. No offering has priced.
JAGX Form 4 activity by transaction type, last 90 days
No Form 4 activity for JAGX in the last 90 days.
JAGX insider transactions (Form 4)
3920 Form 4 filings on record, the earliest from Oct 10, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John Micek | Grant or award | Common Stock | 7,377 | $0.00 | - | |
| John Micek | Grant or award | Stock Option (right to buy) | 7,377 | $0.00 | - | |
| Steven R. King - Officer | Grant or award | Common Stock | 11,740 | $0.00 | - | |
| Steven R. King - Officer | Grant or award | Stock Option (right to buy) | 11,740 | $0.00 | - | |
 Lisa A. Conte - Officer | Grant or award | Common Stock | 28,592 | $0.00 | - | |
| Lisa A. Conte - Officer | Grant or award | Stock Option (right to buy) | 28,592 | $0.00 | - | |
| Jonathan S. Wolin - Officer | Grant or award | Common Stock | 11,740 | $0.00 | - | |
| Jonathan S. Wolin - Officer | Grant or award | Stock Option (right to buy) | 11,740 | $0.00 | - | |
| James J. Bochnowski | Derivative | Convertible Promissory Note | 27,002 | $150,000.00 | $4.05B | |
| James J. Bochnowski | Grant or award | Convertible Promissory Note | 28,388 | $150,000.00 | $4.26B | |
| James J. Bochnowski | Grant or award | Warrant to Purchase Common Stock | 54,786 | - | - | |
| John Micek | Derivative | Convertible Promissory Note | 9,000 | $50,000.00 | $450.00M | |
| John Micek | Grant or award | Convertible Promissory Note | 9,462 | $50,000.00 | $473.10M | |
| John Micek | Grant or award | Warrant to Purchase Common Stock | 18,262 | - | - | |
| Lisa A. Conte - Officer | Derivative | Convertible Promissory Note | 9,000 | $50,000.00 | $450.00M | |
| Lisa A. Conte - Officer | Grant or award | Convertible Promissory Note | 9,462 | $50,000.00 | $473.10M | |
| Lisa A. Conte - Officer | Grant or award | Warrant to Purchase Common Stock | 18,262 | - | - | |
| Lisa A. Conte - Officer | Option exercise | Common Stock | 2 | - | - | |
| Lisa A. Conte - Officer | Option exercise | Restricted stock units | 2 | $0.00 | - | |
| James J. Bochnowski | Open-market purchase | Convertible Promissory Note | 27,002 | $150,000.00 | $4.05B | |
| James J. Bochnowski | Open-market purchase | Warrant to Purchase Common Stock | 27,002 | - | - | |
| John Micek | Open-market purchase | Convertible Promissory Note | 9,000 | $50,000.00 | $450.00M | |
| John Micek | Open-market purchase | Warrant to Purchase Common Stock | 9,000 | - | - | |
| Lisa A. Conte - Officer | Open-market purchase | Convertible Promissory Note | 9,000 | $50,000.00 | $450.00M | |
| Lisa A. Conte - Officer | Open-market purchase | Warrant to Purchase Common Stock | 9,000 | - | - | |
| Carol R. Lizak - Officer | Grant or award | Common Stock | 4,280 | $0.00 | - | |
| Carol R. Lizak - Officer | Grant or award | Stock option (right to buy) | 34,240 | $0.00 | - | |
| Pravin R. Chaturvedi - Officer | Grant or award | Common Stock | 4,922 | $0.00 | - | |
| Pravin R. Chaturvedi - Officer | Grant or award | Stock option (right to buy) | 39,376 | $0.00 | - | |
| Jonathan S. Wolin - Officer | Grant or award | Common Stock | 4,922 | $0.00 | - | |
| Jonathan S. Wolin - Officer | Grant or award | Stock option (right to buy) | 39,376 | $0.00 | - | |
| Anula Jayasuriya | Grant or award | Stock option (right to buy) | 21,000 | $0.00 | - | |
| Steven R. King - Officer | Grant or award | Common Stock | 4,922 | $0.00 | - | |
| Steven R. King - Officer | Grant or award | Stock option (right to buy) | 39,376 | $0.00 | - | |
| Jonathan B. Siegel | Grant or award | Stock option (right to buy) | 26,500 | $0.00 | - | |
| James J. Bochnowski | Grant or award | Stock option (right to buy) | 23,200 | $0.00 | - | |
| John Micek | Grant or award | Stock option (right to buy) | 26,500 | $0.00 | - | |
| Lisa A. Conte - Officer | Grant or award | Common Stock | 16,503 | $0.00 | - | |
| Lisa A. Conte - Officer | Grant or award | Stock option (right to buy) | 132,020 | $0.00 | - |
JAGX insider trading FAQ
What is the latest insider trade for JAGX?
Jaguar Health, Inc. (JAGX) has filed no insider reports in the last 90 days. The most recent on record is dated 12 March 2026. The full record for JAGX runs to 20 Form 4 filings, the earliest from 10 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying JAGX stock?
No insider purchases of JAGX were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling JAGX stock?
No insider sales of JAGX were filed in the last 90 days.
Where can I see JAGX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects JAGX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John Micek view on EDGAR
- - Steven R. King view on EDGAR
- - Lisa A. Conte view on EDGAR
- - Jonathan S. Wolin view on EDGAR
- - James J. Bochnowski view on EDGAR
- - John Micek view on EDGAR
- - Lisa A. Conte view on EDGAR
- - Lisa A. Conte view on EDGAR
- - James J. Bochnowski view on EDGAR
- - John Micek
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where JAGX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow JAGX with a 7-day demo
- JAGX on your watchlist
- Every JAGX Form 4 filing on record
- Up to 3 months of JAGX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
